Varenicline for Methamphetamine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Methamphetamine DependenceSubstance AbuseMethamphetamine Abuse
Interventions
DRUG

Varenicline

Varenicline dosing will follow that which has been shown to be effective for cigarette smoking cessation. Varenicline dose will start at 0.5 mg daily for days 1-3, followed by 0.5 mg twice daily for days 4-7, followed by 1 mg twice daily from day 8 until completion of the medication period (end of week 9).

DRUG

Placebo

Placebo dose will start at 0.5 mg (sugar pill) daily for days 1-3, followed by 0.5 mg twice daily for days 4-7, followed by 1 mg twice daily from day 8 until completion of the medication period (end of week 9).

Trial Locations (1)

90036

UCLA Vine Street Clinic, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT01365819 - Varenicline for Methamphetamine Dependence | Biotech Hunter | Biotech Hunter